---
document_datetime: 2025-12-02 05:24:23
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/imprida-hct.html
document_name: imprida-hct.html
version: success
processing_time: 0.1032844
conversion_datetime: 2025-12-27 14:44:50.551276
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Imprida HCT

[RSS](/en/individual-human-medicine.xml/66076)

##### Lapsed

This medicine's authorisation has lapsed

amlodipine / valsartan / hydrochlorothiazide Medicine Human Lapsed

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Imprida HCT](#news-on)
- [More information on Imprida HCT](#more-information-on-imprida-hct-1193)
- [More information on Imprida HCT](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 15 October 2009, the European Commission granted a marketing authorisation valid throughout the European Union (EU) for the medicinal product Imprida HCT (amlodipine/valsartan/hydrochlorothiazide), indicated for the treatment of essential hypertension. The marketing authorisation holder was notified on the 19 October 2009.

Imprida HCT (amlodipine/valsartan/hydrochlorothiazide) had not been marketed in Europe since this initial marketing authorisation. In accordance with article 14(4) of Regulation (EC) No 726/2004 ('sunset clause'), the marketing authorisation of a medicinal product lapses if the product has never been marketed in one of the Member States within three years of its initial authorisation.

Because of this, from 20 October 2012, the marketing authorisation for Imprida HCT is no longer valid.

Pursuant to the expiry of the marketing authorisation, the European Assessment Report (EPAR) for Imprida HCT is updated to reflect that the marketing authorisation is no longer valid.

Imprida HCT : EPAR - Summary for the public

English (EN) (288.49 KB - PDF)

**First published:** 12/11/2009

**Last updated:** 29/10/2012

[View](/en/documents/overview/imprida-hct-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-681)

български (BG) (457.79 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/bg/documents/overview/imprida-hct-epar-summary-public_bg.pdf)

español (ES) (271.57 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/es/documents/overview/imprida-hct-epar-summary-public_es.pdf)

čeština (CS) (400.76 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/cs/documents/overview/imprida-hct-epar-summary-public_cs.pdf)

dansk (DA) (268.79 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/da/documents/overview/imprida-hct-epar-summary-public_da.pdf)

Deutsch (DE) (272.53 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/de/documents/overview/imprida-hct-epar-summary-public_de.pdf)

eesti keel (ET) (267.31 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/et/documents/overview/imprida-hct-epar-summary-public_et.pdf)

ελληνικά (EL) (467.91 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/el/documents/overview/imprida-hct-epar-summary-public_el.pdf)

français (FR) (272.67 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/fr/documents/overview/imprida-hct-epar-summary-public_fr.pdf)

italiano (IT) (270.98 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/it/documents/overview/imprida-hct-epar-summary-public_it.pdf)

latviešu valoda (LV) (427.68 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/lv/documents/overview/imprida-hct-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (379.27 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/lt/documents/overview/imprida-hct-epar-summary-public_lt.pdf)

magyar (HU) (402.1 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/hu/documents/overview/imprida-hct-epar-summary-public_hu.pdf)

Malti (MT) (432.85 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/mt/documents/overview/imprida-hct-epar-summary-public_mt.pdf)

Nederlands (NL) (272.05 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/nl/documents/overview/imprida-hct-epar-summary-public_nl.pdf)

polski (PL) (422.76 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/pl/documents/overview/imprida-hct-epar-summary-public_pl.pdf)

português (PT) (272.29 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/pt/documents/overview/imprida-hct-epar-summary-public_pt.pdf)

română (RO) (396.93 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/ro/documents/overview/imprida-hct-epar-summary-public_ro.pdf)

slovenčina (SK) (396.05 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/sk/documents/overview/imprida-hct-epar-summary-public_sk.pdf)

slovenščina (SL) (356.52 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/sl/documents/overview/imprida-hct-epar-summary-public_sl.pdf)

Suomi (FI) (268.08 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/fi/documents/overview/imprida-hct-epar-summary-public_fi.pdf)

svenska (SV) (268.58 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/sv/documents/overview/imprida-hct-epar-summary-public_sv.pdf)

## Product information

Imprida HCT : EPAR - Product Information

English (EN) (4.04 MB - PDF)

**First published:** 12/11/2009

**Last updated:** 29/10/2012

[View](/en/documents/product-information/imprida-hct-epar-product-information_en.pdf)

[Other languages (23)](#file-language-dropdown-86)

български (BG) (8.15 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/bg/documents/product-information/imprida-hct-epar-product-information_bg.pdf)

español (ES) (4.13 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/es/documents/product-information/imprida-hct-epar-product-information_es.pdf)

čeština (CS) (6.17 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/cs/documents/product-information/imprida-hct-epar-product-information_cs.pdf)

dansk (DA) (4.24 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/da/documents/product-information/imprida-hct-epar-product-information_da.pdf)

Deutsch (DE) (4.34 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/de/documents/product-information/imprida-hct-epar-product-information_de.pdf)

eesti keel (ET) (4.27 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/et/documents/product-information/imprida-hct-epar-product-information_et.pdf)

ελληνικά (EL) (8.33 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/el/documents/product-information/imprida-hct-epar-product-information_el.pdf)

français (FR) (4.45 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/fr/documents/product-information/imprida-hct-epar-product-information_fr.pdf)

íslenska (IS) (4.07 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/is/documents/product-information/imprida-hct-epar-product-information_is.pdf)

italiano (IT) (4.26 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/it/documents/product-information/imprida-hct-epar-product-information_it.pdf)

latviešu valoda (LV) (6.37 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/lv/documents/product-information/imprida-hct-epar-product-information_lv.pdf)

lietuvių kalba (LT) (4.62 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/lt/documents/product-information/imprida-hct-epar-product-information_lt.pdf)

magyar (HU) (6.42 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/hu/documents/product-information/imprida-hct-epar-product-information_hu.pdf)

Malti (MT) (6.75 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/mt/documents/product-information/imprida-hct-epar-product-information_mt.pdf)

Nederlands (NL) (4.11 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/nl/documents/product-information/imprida-hct-epar-product-information_nl.pdf)

norsk (NO) (4.14 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/no/documents/product-information/imprida-hct-epar-product-information_no.pdf)

polski (PL) (6.65 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/pl/documents/product-information/imprida-hct-epar-product-information_pl.pdf)

português (PT) (4.15 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/pt/documents/product-information/imprida-hct-epar-product-information_pt.pdf)

română (RO) (4.55 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/ro/documents/product-information/imprida-hct-epar-product-information_ro.pdf)

slovenčina (SK) (6.41 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/sk/documents/product-information/imprida-hct-epar-product-information_sk.pdf)

slovenščina (SL) (6.23 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/sl/documents/product-information/imprida-hct-epar-product-information_sl.pdf)

Suomi (FI) (4.16 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/fi/documents/product-information/imprida-hct-epar-product-information_fi.pdf)

svenska (SV) (4.13 MB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/sv/documents/product-information/imprida-hct-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** WS/0250/G 20/10/2012

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Imprida HCT : EPAR - All Authorised presentations

English (EN) (20.74 KB - PDF)

**First published:** 12/11/2009

**Last updated:** 29/10/2012

[View](/en/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_en.pdf)

[Other languages (21)](#file-language-dropdown-610)

български (BG) (396.01 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/bg/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_bg.pdf)

español (ES) (268.27 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/es/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_es.pdf)

čeština (CS) (356.37 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/cs/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (265.53 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/da/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (267.75 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/de/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (268.84 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/et/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (398.88 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/el/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_el.pdf)

français (FR) (268.81 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/fr/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_fr.pdf)

italiano (IT) (267.58 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/it/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (362.09 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/lv/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (330.83 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/lt/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (373.98 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/hu/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (357.51 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/mt/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (266.04 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/nl/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_nl.pdf)

polski (PL) (323.76 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/pl/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_pl.pdf)

português (PT) (266.79 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/pt/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_pt.pdf)

română (RO) (329.9 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/ro/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (343.45 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/sk/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (302.87 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/sl/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (268.72 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/fi/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (260.58 KB - PDF)

**First published:**

12/11/2009

**Last updated:**

29/10/2012

[View](/sv/documents/all-authorised-presentations/imprida-hct-epar-all-authorised-presentations_sv.pdf)

## Product details

Name of medicine Imprida HCT Active substance

- amlodipine
- valsartan
- hydrochlorothiazide

International non-proprietary name (INN) or common name

- amlodipine
- valsartan
- hydrochlorothiazide

Therapeutic area (MeSH) Hypertension Anatomical therapeutic chemical (ATC) code C09DX01

### Pharmacotherapeutic group

- Angiotensin II antagonists, plain
- Angiotensin II antagonists, combinations

### Therapeutic indication

Treatment of essential hypertension as substitution therapy in adult patients whose blood pressure is adequately controlled on the combination of amlodipine, valsartan and hydrochlorothiazide (HCT), taken either as three single-component formulations or as a dual-component and a single-component formulation.

## Authorisation details

EMA product number EMEA/H/C/001161 Marketing authorisation holder

Novartis Europharm Ltd.

Novartis Europharm Limited

Marketing authorisation issued 15/10/2009 Lapse of marketing authorisation 20/10/2012 Revision 3

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Imprida HCT : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (419.51 KB - PDF)

**First published:** 04/11/2010

**Last updated:** 29/10/2012

[View](/en/documents/procedural-steps-after/imprida-hct-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Imprida HCT : EPAR - Public assessment report

English (EN) (1.02 MB - PDF)

**First published:** 12/11/2009

**Last updated:** 29/10/2012

[View](/en/documents/assessment-report/imprida-hct-epar-public-assessment-report_en.pdf)

#### News on Imprida HCT

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 October 2011](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-17-20-october-2011) 21/10/2011

[European Medicines Agency concludes that benefit-risk balance of angiotensin-II-receptor antagonists remains positive](/en/news/european-medicines-agency-concludes-benefit-risk-balance-angiotensin-ii-receptor-antagonists-remains-positive) 20/10/2011

#### More information on Imprida HCT

Questions and answers on the review of angiotensin-II-receptor antagonists and the risk of cancer

Reference Number: EMA/CHMP/834168/2011

English (EN) (511.41 KB - PDF)

**First published:** 20/10/2011

**Last updated:** 11/05/2017

[View](/en/documents/opinion-any-scientific-matter/questions-answers-review-angiotensin-ii-receptor-antagonists-risk-cancer_en.pdf)

#### More information on Imprida HCT

- [EMEA-000399-PIP01-08 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000399-pip01-08)

**This page was last updated on** 22/10/2012

## Share this page

[Back to top](#main-content)